Israeli company Brainsway says its patented helmet provides a non-invasive, but highly effective treatment for depression and other neurological disorders, Reuters reports. The device sends targeted electromagnetic pulses into the brain and stimulates previously unreachable neurons in affected areas.

This method is called transcranial magnetic stimulation, and it is a better and safer version of conventional electro-shock therapy, according to Chief Technology Officer Ronen Segal.

The company received a major boost last year when the US Food and Drug Administration approved the system to treat patients suffering from major depression. But Segal says the helmet is capable of doing much more. He says trials for treating diseases such as Parkinson's and Alzheimer's are showing promising results.

So far, Brainsway has sold more than 70 units, mostly in the United States, but sees a bright future all over the world, both for the company and its patients.